Therefore, one of the therapeutic strategies used to slow down the progression of AD symptoms is related to the enhancement of acetylcholine levels, throughthe inhibition of cholinesterases (ChE) located in cholinergic synaptic cleft areas [4,5,6]. The gene discussed is BCHE; the disease is Alzheimer disease.